Importance of parallel vectors and "hydrophobic collapse" of the aligned aromatic rings: discovery of a potent substance P antagonist.

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Journal of Medicinal Chemistry

• Publication date

  1994-12-09

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1021/JM00051A001PMID 7527861
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Tachykinin receptors and tachykinin receptor antagonists.

  1993cited by this paper
• Peptidomimetics derived from natural products

  1993cited by this paper
• Pharmacology of CP-99,994; a nonpeptide antagonist of the tachykinin neurokinin-1 receptor.

  1993cited by this paper
• Discovery of a potent substance P antagonist: recognition of the key molecular determinant.

  1992cited by this paper
• Benzene Forms Hydrogen Bonds with Water

  1992cited by this paper
• The discovery of (2S,3S)-cis-2-(diphenylmethyl)-N-[(2-methoxyphenyl)methyl]-1- azabicyclo[2.2.2]-octan-3-amine as a novel, nonpeptide substance P antagonisst.

  1992cited by this paper
• Activity and distribution of binding sites in brain of a nonpeptide substance P (NK1) receptor antagonist.

  1991cited by this paper
• A potent nonpeptide antagonist of the substance P (NK1) receptor.

  1991cited by this paper

• Toward the Validation of Maternal Embryonic Leucine Zipper Kinase: Discovery, Optimization of Highly Potent and Selective Inhibitors, and Preliminary Biology Insight.

  2016cites this paper
• (±)-CSA catalyzed one-pot synthesis of 6,7-dihydrospiro[indole-3,1′-isoindoline]-2,3′,4(1H,5H)-trione derivatives: easy access of spirooxindoles and ibophyllidine-like alkaloids

  2014cites this paper
• Effects of structure on inhibitory activity in a series of mechanism-based inhibitors of human neutrophil elastase.

  2010cites this paper
• Stereoselective ring contraction of 2,5-diketopiperazines: An innovative approach to the synthesis of promising bioactive 5-membered scaffolds.

  2010cites this paper
• Tachykinin receptors antagonists: from research to clinic.

  2006cites this paper
• An expedient route to diaza-spirocycles utilizing a sequential multicomponent α-aminoallylation/ring-closing metathesis strategy

  2006cites this paper
• Design, synthesis, and evaluation of novel 2-substituted-4-aryl-6,7,8,9-tetrahydro-5H-pyrimido[4,5-b][1,5]oxazocin-5-ones as NK1 antagonists.

  2005cites this paper
• 1H NMR study of the conformation and absolute stereochemistry of two spirocyclic NK‐1 antagonists

  2005cites this paper
• Solution phase parallel synthesis and evaluation of MAPK inhibitory activities of close structural analogues of a Ras pathway modulator.

  2004cites this paper
• Medicinal chemistry of selective neurokinin-1 antagonists.

  2003cites this paper
• Pharmacophore and receptor models for neurokinin receptors

  2003cites this paper
• Conformational analysis of tandospirone in aqueous solution: lead evolution of potent dopamine D4 receptor ligands.

  2001cites this paper
• P-glycoprotein efflux at the blood-brain barrier mediates differences in brain disposition and pharmacodynamics between two structurally related neurokinin-1 receptor antagonists.

  2001cites this paper
• Axially chiral 1,7-naphthyridine-6-carboxamide derivatives as orally active tachykinin NK(1) receptor antagonists: synthesis, antagonistic activity, and effects on bladder functions.

  1999cites this paper
• Chemical modulation of activity in steroidal estrogens.

  1999cites this paper
• Recent advances in neurokinin receptor antagonists.

  1999cites this paper
• Derivation of a three-dimensional pharmacophore model of substance P antagonists bound to the neurokinin-1 receptor.

  1998cites this paper
• Axially chiral N-benzyl-N,7-dimethyl-5-phenyl-1, 7-naphthyridine-6-carboxamide derivatives as tachykinin NK1 receptor antagonists: determination of the absolute stereochemical requirements.

  1998cites this paper
• Concise and regiospecific syntheses of tri-substituted 1,2,4-triazoles

  1998cites this paper
• Potent NK1 receptor antagonists: synthesis and antagonistic activity of various heterocycles with an N-[3,5-bis(trifluoromethyl)benzyl]-N-methylcarbamoyl substituent.

  1997cites this paper
• Possible ligand-receptor interactions for NK1 antagonists as observed in their crystal structures.

  1997cites this paper
• New synthesis and characterization of (+)-lysergic acid diethylamide (LSD) derivatives and the development of a microparticle-based immunoassay for the detection of LSD and its metabolites.

  1997cites this paper
• A structural rationale for the design of water soluble peptide-derived neurokinin-1 antagonists.

  1997cites this paper
• 1,4-Benzodiazepin-2-one derived neurokinin-1 receptor antagonists

  1997cites this paper
• Studies on the active conformation of the NK1 antagonist CGP 49823. Part 21. Fluoro-olefin analogs of tertiary amide rotamers.

  1997cites this paper
• Tandem Michael addition and azanorbornane substance-P antagonists

  1997cites this paper
• The tachykinin NK1 receptor. Part I: ligands and mechanisms of cellular activation.

  1997cites this paper
• A STRUCTURAL RATIONALE FOR THE DESIGN OF ANTAGONISTS WATER SOLUBLE PEPTIDE-DERIVED NEUROKININ-1

  1997cites this paper
• ligands and mechanisms of cellular activation

  1997cites this paper
• Nonpeptide tachykinin antagonists: medicinal chemistry and molecular biology

  1996cites this paper
• Systematic search strategies in conformational analysis

  1996cites this paper
• Synthesis and NK-2 antagonist effect of 1,6-diphenyl-pyrazolo [3,4-d]-thiazolo[3,2-a]4H-pyrimidin-4-one

  1996cites this paper
• SPIRO-PIPERIDINE NON-PEPTIDE NEUROKININ-1 RECEPTOR ANTAGONISTS

  1995cites this paper
• Photoactivatable analogues of a Substance P non-peptidic antagonist, for probing the antagonist binding site of the NK1 receptor

  1995cites this paper
• Novel, potent, and orally active substance P antagonists: synthesis and antagonist activity of N-benzylcarboxamide derivatives of pyrido[3,4-b]pyridine.

  1995cites this paper